PROCHLORPERAZINE SUPPOSITORIES USP, 25mg
Prochlorperazine is a clear, pale yellow, viscous liquid. It is sensitive to light, very slightly soluble in water, freely soluble in alcohol, in chloroform, and in ether. Each suppository, for rectal administration, contains 25 mg of prochlorperazine; with glycerin, glyceryl monopalmitate, glyceryl monostearate, hydrogenated coconut oil fatty acids and hydrogenated palm kernel oil fatty acids.
Prochlorperazine 25mg suppositories are indicated in the control of severe nausea and vomiting in adults.
Media Articles Related to Compro (Prochlorperazine Rectal)
Survivors of childhood liver transplant at risk of becoming "skinny fat"
Source: Transplants / Organ Donations News From Medical News Today [2014.06.13]
New research reports that survivors of childhood liver transplant remain nutritionally compromised over the long-term.
Next-Gen DNA Testing IDs Rare Infection (CME/CE)
Source: MedPage Today Radiology [2014.06.05]
(MedPage Today) -- Next-generation DNA sequencing allowed presumptive diagnosis and successful targeted treatment for neuroleptospirosis in an immunocompromised adolescent boy, researchers reported.
Research has implications for understanding brain diseases caused by clumps of misshapen molecules
Source: Muscular Dystrophy / ALS News From Medical News Today [2014.06.02]
It's almost axiomatic that misfolded proteins compromise how cells normally function and cause debilitating human disease, but how these proteins are detected and degraded within the body is not well...
Nausea and Vomiting
Source: MedicineNet Alcohol Abuse and Alcoholism Specialty [2014.07.09]
Title: Nausea and Vomiting
Category: Diseases and Conditions
Created: 1/31/2005 8:21:00 AM
Last Editorial Review: 7/9/2014 12:00:00 AM
Emesis Combo Quells CINV in Three Trials (CME/CE)
Source: MedPage Today Oncology/Hematology [2014.07.22]
(MedPage Today) -- A single-dose antiemetic regimen provided superior control of chemotherapy-induced nausea and vomiting as compared with a standard multidose regimen, according to results from multiple trials.
Published Studies Related to Compro (Prochlorperazine Rectal)
Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache. [2011.04.01]
The indomethacin/prochlorperazine/caffeine fixed combination (Difmetre(R)) combines the NSAID indomethacin with the phenothiazine antiemetic prochlorperazine and caffeine. It is currently available as two oral (effervescent tablet and coated tablet) and two rectal (suppository and low-dose suppository) formulations...
Clinical Trials Related to Compro (Prochlorperazine Rectal)
StaccatoŽ Prochlorperazine for Inhalation [Completed]
Staccato Prochlorperazine in Patients With Migraine Headache [Completed]
Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department [Completed]
ED patients with acute migraine will be randomized to either prochlorperazine and Bendaryl OR
imitrex. VAS for pain will be monitored, along with side effects. Primary outcome measure is
improvement in pain scales between the groups.
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department [Recruiting]
This study will compare the effect of prochlorperazine and ondansetron for the treatment of
nausea and vomiting in the emergency department.
StaccatoŽ Prochlorperazine for Inhalation in Migraine [Completed]
Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine
headaches. In October 2005, we completed a 75 patient, multi-center, double-blind
placebo-controlled Phase 2A clinical trial in patients suffering from moderate to severe
acute migraine headaches. This Phase 2B clinical trial of Staccato Prochlorperazine has been
initiated to assess the efficacy and safety in outpatients with migraine headache with or